The GMO U.S. Equity Strategy seeks to generate high total return by investing primarily in U.S. equities. The Strategy measures its performance against the S&P Composite 1500+ Index. 

The Strategy’s investment approach is grounded in the Systematic Equity team’s belief that, in the short term, equity markets exhibit exploitable inefficiencies as a result of irrational investor actions, the imperfect flow of information, and the participation of non-economic actors, while in the long-term returns are ultimately driven by economic reality. The Strategy aims to take advantage of these inefficiencies by utilizing a multi-factor valuation model in conjunction with other methods, such as cross-asset signals and corporate alerts, to identify undervalued equity securities. 





Fact Sheet Download
Product Primer Download
GIPS® Composite Report Download
Composite Descriptions Download
Download All Download


Performance Download
Portfolio Composition Download
Download All Download

Commentary & Attribution

Commentary Quarterly Download
Market Review Download
Year-End Letter Download
Attribution - Monthly Download
Attribution - Quarterly Download
Attribution - YTD Download
Download All Download


Risks associated with investing in the Strategy may include Market Risk - Equities, Management and Operational Risk, Focused Investment Risk, Illiquidity Risk, and Derivatives and Short Sales Risk.